GlassScriptPhysician profile
Kathlyn Kim
NPI 1730174715
$1,352.14
in general payments reported to CMS, 2019-2025
16 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $35.53 · 2021: $385 · 2022: $210 · 2023: $174 · 2024: $40.05 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395 · Education: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.27 |
| Education | $152.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $257.36 | 2022-2025 | |
| Millicent US INC | $254.86 | 2021-2024 | Femring, Intrarosa |
| Astellas Pharma US INC | $148.79 | 2019-2025 | Veozah, Myrbetriq |
| Evofem Biosciences, INC. | $134.09 | 2021-2023 | Phexxi |
| Abbvie INC. | $128.95 | 2019-2023 | |
| Therapeuticsmd, INC. | $99.97 | 2019-2021 | |
| Pfizer INC. | $85.83 | 2019-2023 | |
| Avion Pharmaceuticals | $48.99 | 2021-2023 | Balcoltra |
| Allergan, INC. | $38.11 | 2019 | |
| Lupin INC. | $37.36 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $30.58 | 2022 | |
| Virtus Pharmaceuticals LLC | $30.35 | 2021 | |
| Sumitomo Pharma America, INC. | $16.06 | 2023 | Myfembree |
| Myovant Sciences INC. | $15.00 | 2022 | |
| Vertical Pharmaceuticals, LLC | $14.10 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $11.74 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathlyn Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.